Standard BioTools to pay $890,000 to settle attorneys' fees in stockholder disclosure lawsuit

STANDARD BIOTOOLS INC.

Standard BioTools will pay $890,000 to plaintiffs' counsel to resolve mootness fee application in class action over proxy disclosures.
Settlement does not constitute admission of wrongdoing; SomaLogic denies all allegations.
Delaware Court entered order requiring notice via 8-K; court did not pass judgment on reasonableness of payment.
Lawsuit filed Dec 2023 alleged false/misleading proxy in SomaLogic merger; supplemental disclosures mooted claims.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.